S&P 500:  2,801.31  +3.02 (+0.11%)
DOW:  25,019.41  +94.52 (+0.38%)
NASDAQ:  7,825.98  +2.06 (+0.03%)

NASDAQ:CUE - Cue Biopharma News Headlines

Sign in or create an account to add this stock to your watchlist.
Get Started
$11.83 -0.06 (-0.50 %)
(As of 07/16/2018 04:47 AM ET)
Previous Close$11.83
Today's Range$11.37 - $12.02
52-Week Range$10.30 - $17.99
Volume30,577 shs
Average Volume130,863 shs
Market Capitalization$238.15 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Cue Biopharma (NASDAQ CUE) News Headlines

Source:
DateHeadline
Cue Biopharma (CUE) Reports Progress in Ongoing Strategic Collaboration & License Agreement with Merck (MRK) to Develop Immuno-STATsCue Biopharma (CUE) Reports Progress in Ongoing Strategic Collaboration & License Agreement with Merck (MRK) to Develop Immuno-STATs
www.streetinsider.com - July 12 at 10:17 AM
Cue Biopharma Produces Immuno-STAT™ Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with MerckCue Biopharma Produces Immuno-STAT™ Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
finance.yahoo.com - July 12 at 10:17 AM
Cue Biopharma Inc (CUE) CEO Daniel R. Passeri Acquires 1,600 SharesCue Biopharma Inc (CUE) CEO Daniel R. Passeri Acquires 1,600 Shares
www.americanbankingnews.com - June 30 at 4:28 AM
Form 8-K Cue Biopharma, Inc. For: Jun 26Form 8-K Cue Biopharma, Inc. For: Jun 26
www.streetinsider.com - June 27 at 10:33 AM
Cue Biopharma Incs (CUE) Lock-Up Period Will Expire on July 2ndCue Biopharma Inc's (CUE) Lock-Up Period Will Expire on July 2nd
www.americanbankingnews.com - June 25 at 1:20 AM
Cue Biopharma (CUE) Releases Quarterly Earnings ResultsCue Biopharma (CUE) Releases Quarterly Earnings Results
www.americanbankingnews.com - May 16 at 11:44 AM
Cue Biopharma to Host Investor Business Update Call and WebcastCue Biopharma to Host Investor Business Update Call and Webcast
finance.yahoo.com - May 10 at 8:49 AM
BRIEF-Cue Biopharma - On April 30,Gary Schuman Resigned As Interim CFOBRIEF-Cue Biopharma - On April 30,Gary Schuman Resigned As Interim CFO
www.reuters.com - May 1 at 8:45 AM
Cue Biopharma Announces Appointment of Anish Suri, Ph.D. as Chief Scientific OfficerCue Biopharma Announces Appointment of Anish Suri, Ph.D. as Chief Scientific Officer
finance.yahoo.com - April 25 at 8:33 AM
Cue Biopharma to Present at Bloomberg Biotech Innovations ConferenceCue Biopharma to Present at Bloomberg Biotech Innovations Conference
finance.yahoo.com - April 5 at 9:45 AM
BRIEF-Peter Appel Reports Passive Stake Of 7.6 Pct In Cue BiopharmaBRIEF-Peter Appel Reports Passive Stake Of 7.6 Pct In Cue Biopharma
www.reuters.com - February 14 at 8:01 AM
Cue Biopharma to Present at BIO CEO & Investor ConferenceCue Biopharma to Present at BIO CEO & Investor Conference
finance.yahoo.com - February 8 at 10:00 AM
Cue Biopharma Incs (CUE) Quiet Period Set To Expire on February 12thCue Biopharma Inc's (CUE) Quiet Period Set To Expire on February 12th
www.americanbankingnews.com - February 5 at 1:16 AM
Cue Biopharma to Provide Corporate Update at the 10th Annual Biotech Showcase 2018 ConferenceCue Biopharma to Provide Corporate Update at the 10th Annual Biotech Showcase 2018 Conference
finance.yahoo.com - January 27 at 8:00 AM
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Featured Article: Earnings Per Share
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.